Your browser doesn't support javascript.
The Impact of Lung Ultrasound on Coronavirus Disease 2019 Pneumonia Suspected Patients Admitted to Emergency Departments.
Öztürk Sönmez, Leyla; Katipoglu, Burak; Vatansev, Hülya; Kaykisiz, Eylem Kuday; Yüce, Nalan; Szarpak, Lukasz; Evrin, Togay.
  • Katipoglu B; Department of Emergency Medicine, Ufuk University Medical Faculty, Ankara.
  • Vatansev H; Department of Chest Diseases, Meram Medical Faculty, Necmettin Erbakan University, Konya.
  • Kaykisiz EK; Department of Emergency Medicine, Denizli State Hospital, Denizli, Turkey.
  • Yüce N; Department of Emergency Medicine, Ufuk University Medical Faculty, Ankara.
  • Evrin T; Department of Emergency Medicine, Ufuk University Medical Faculty, Ankara.
Ultrasound Q ; 37(3): 261-266, 2021 Mar 03.
Article in English | MEDLINE | ID: covidwho-1413343
ABSTRACT

OBJECTIVE:

The aim of this study was to identify the sensitivity and specificity of lung ultrasound (LUS) and show its place in diagnosing patients with known coronavirus disease 2019 (COVID-19) pneumonia, according to chest computed tomography and the COVID-19 reporting and data system (CO-RADS).

METHODS:

Nineteen patients who admitted to a single university hospital emergency department between March 5, 2020, and April 27, 2020, describing dyspnea were included in the study and underwent LUS by a single emergency specialist. The patient population was divided into 2 groups, COVID-19 positive and negative, and the sensitivity and specificity of LUS according to chest computed tomography were calculated for COVID-19 pneumonia diagnosis. In the subgroup analysis, the patient group was divided into real-time reverse transcription-polymerase chain reaction positive (n = 7) and negative (n = 12), and sensitivity and specificity were calculated according to the CO-RADS.

RESULTS:

According to the CO-RADS, significant differences were detected between the LUS positive and negative groups in terms of COVID-19 pneumonia presence. Only 1 patient was evaluated as CO-RADS 2 in the LUS positive group, and 2 patients were evaluated as CO-RADS 4 in the LUS negative group (P = 0.04). The sensitivity of LUS according to the CO-RADS for COVID-19 pneumonia diagnosis was measured to be 77.78% (95% confidence interval [CI], 39.9%-97.1%), specificity was 90% (95% CI, 55.5%-99.75%), positive predictive value was 87.5% (95% CI, 51.35%-97.8%), and accuracy was 84.21% (95% CI, 60.4%-96.62%; P = 0.004).

CONCLUSIONS:

In conclusion, LUS is easily used in the diagnosis of COVID-19 pneumonia because it has bedside application and is fast, easy to apply, reproducible, radiation free, safe for pregnant women, and cheap.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ultrasonography / Emergency Service, Hospital / Pandemics / SARS-CoV-2 / COVID-19 / Lung Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: Ultrasound Q Journal subject: Diagnostic Imaging Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ultrasonography / Emergency Service, Hospital / Pandemics / SARS-CoV-2 / COVID-19 / Lung Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: Ultrasound Q Journal subject: Diagnostic Imaging Year: 2021 Document Type: Article